PANEL: Next-Generation Monoclonal Antibodies - Expanding Targets and Extending Impact

Monoclonal antibodies are redefining therapeutic possibilities in animal health, offering precise, targeted alternatives to traditional treatments. With next-generation innovation expanding into new disease areas and species, changemakers at the forefront examine the opportunities and hurdles that will shape development, approval, and adoption.

• Regulatory pathways – navigating approval processes for novel biologics
• Clinical adoption – driving veterinary education and confidence in new therapies